Get startedLog in
    Picture of Mithra Pharmaceuticals SA logo

    MITRA — Mithra Pharmaceuticals SA News Story

    0.000.00%
    be flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Mithra: New Positive Preclinical Data From CSF-1R Inhibitor Program

    Picture of Mithra Pharmaceuticals SA logoMithra Pharmaceuticals SA
    15/06/2023 06:33
    June 15 (Reuters) - Mithra Pharmaceuticals SA
 MITRA.BR :
    * MITHRAANNOUNCES NEW POSITIVE PRECLINICAL DATA FROM CSF-1R
INHIBITOR PROGRAM
    * CSF-1R INHIBITORS SHOW PROMISING ANTI-TUMOR ACTIVITY
    * LEAD COMPOUND SHOWS SYNERGY WITH PD1 CANCER IMMUNE
CHECKPOINT
INHIBITOR
    * PRECLINICAL DEVELOPMENT CONDUCTED IN PARTNERSHIP WITH BCI
PHARMA

Source text for Eikon:  ID:nGNE1cSbWJ 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Mithra Pharmaceuticals SA

    See all news